CERT vs RMD · rev $385.1M vs P/E 29, $37.68B cap
Certara Inc (CERT) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
RMD does not have a complete income-statement cache yet.
CERT currently screens at market cap $1.86B. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the CERT and RMD stock pages for the full models.
Not investment advice.